News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aerie Pharmaceuticals, Inc. (AERI) Names Craig R. Skenes As Vice President, Business Development


6/17/2014 1:29:04 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that Craig R. Skenes has been named to the newly established position of Vice President, Business Development at Aerie, reporting directly to Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer. Mr. Skenes has more than two decades of experience in the healthcare industry, having held senior business development leadership positions within ophthalmology and biopharma firms.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES